Testing effectiveness (Phase 2)Study completedNCT03679598
What this trial is testing
Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency
Who this might be right for
Alpha-1 Antitrypsin Deficiency (AATD)Pi*ZZ, Pi*SZ, Pi*Null, Another Rare Phenotype/Genotype Known to be Associated With Either Low or Functionally Impaired AAT Including F or I MutationsEmphysema or COPD
University of Alabama at Birmingham 63